Critical IllnessNCT02247895
Treatment of Muscle Weakness in Critically Ill Patients
A study testing Electrical stimulation in people with Critical Illness and Respiratory Failure, run by Gerald Supinski at 1 site in United States.
Trial summary
Patients who are admitted to the intensive care unit and require mechanical ventilation frequently develop profound respiratory and limb muscle weakness. Studies show that the development of weakness during the ICU stay results in poor outcomes. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Critical Illness, Respiratory Failure, Myopathy
- What is being tested?
- Electrical stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 2 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2016to Feb 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Acute respiratory failure requiring mechanical ventilation
Who cannot join
- Attending physician on service determines that patient too unstable to tolerate measurements
- Patient requires > 15mcg/min norepinephrine or > 15mg/kg/min of dopamine.
- Fraction of inspired oxygen > 80% or positive end expiratory pressure > 15 cm H20 requirements.
- Cardiac pacemaker or implanted defibrillator.
- Neuromuscular blocking agents delivered within 48 hours of preceding testing.
- Existing neuromuscular disease.
Show all 15Show fewer
- Profound uncorrectable hypokalemia (< 2.5) OR hypophosphatemia (< 1.0)
- Acute lower extremity deep vein thrombosis
- Pregnancy
- Prisoner
- Institutionalized patient
- If primary attending determines that patient is terminal and will likely have care withdrawn within 7 days
- Do not resuscitate order
- Body mass index > 40
- Patients requiring mechanical ventilation more than 4 days prior to study entry
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Kentucky Medical Center
Lexington, Kentucky, 40586
About this study
Official title: Effect of Treatment With the Niveus Medical Muscle Stimulation System 110 on Quadriceps Strength In Mechanically Ventilated Patients
Patients who are admitted to the intensive care unit and require mechanical ventilation frequently develop profound respiratory and limb muscle weakness. Studies show that the development of weakness during the ICU stay results in poor outcomes. Currently there are no treatments for this muscle weakness, but it has been suggested that this weakness might improve with physical therapy. Electrical stimulation is a method to provide direct stimulation to the muscles potentially enhancing function and improving strength. The purpose of this study is to test the hypothesis that neuromuscular electrical stimulation of the quadriceps muscle will improve muscle strength in patients who are critically ill on mechanical ventilation.
Read the detailed description
The basic study design is to:
- Obtain informed consent from patient or the patients LAR
- Randomize subjects to treatment with either:
- Sham therapy, consisting of bilateral placement of Niveus Medical Muscle Stimulation System 110 electrodes for 30 minutes twice daily without activation of the electrical circuitry of the unit, or
- Active therapy, using the Niveus Medical Muscle Stimulation System 110 electrodes to actively produce a rhythmic quadriceps contraction for 30 minutes twice daily
- Measure magnetic stimulated quadriceps twitch (QuadTw) strength bilaterally as well as ultrasound assessment of quadriceps size
- Continue sham or active treatment daily for 7 days for a total of 14 sessions
- Repeat measurements of magnetic stimulated QuadTw strength and ultrasound assessment of quadriceps size on Day 8 or before Day 8 if the subject is to be discharged from the hospital prior to the allotted duration of sham or active treatment
- Functional measurement of the patient using the Functional Status Score for the ICU (FSS-ICU) at the end of the treatment period or upon discharge
- A member of the research team will visit the subject until hospital discharge and will record total duration (days) of mechanical ventilation, duration (days) of mechanical ventilation following study entry, duration of ICU stay, ventilator weaning time (days measured from time of first spontaneous breathing trial to extubation), and total duration (days) of hospitalization
- The investigators will also review each subject's medical record on entry into the study to obtain demographic information including the following: age, sex, diagnoses, medications, reason for institution of mechanical ventilation, vital signs at the time of the initial visit, bedside parameters of mechanical ventilation use (including mode of ventilation, duration of ventilation, level of oxygen, breath volume and rate, % triggered breaths), most recent arterial blood gas values, and chest radiograph readings at the time of the initial visit. The investigators will also record the subject's weight, BMI and total intake and output values since admission to the ICU. In addition, investigators will monitor each subject's progress in the ICU daily by reviewing the subject's medical record and recording the clinical parameters as well as recording daily weights and total intake and output. These parameters will also be assessed until the time that the patient is discharged from the ICU. In addition, the investigators will record and note all physical therapy and occupational therapy sessions that the subject receives as part of the standard of care in the ICU and in the hospital up until the time of discharge. In the University of Kentucky hospital, occupational therapy records the Barthel Index at each session which uses a scale of 0-100 to assess an individual's functional independence when performing activities of daily living (ADLs). Physical therapy assesses functional status using Kansas University Hospital Physical Therapy Acute Care Functional Outcomes, which also assesses functional status in the categories of bed mobility, transfer, gait and walking distance.
- Conditions
- Critical Illness, Respiratory Failure, Myopathy, Weakness
- Being tested
- Sham Treatment, Electrical stimulation
- Keywords
- ICU Acquired weakness, Critical illness, Mechanical ventilation
- Medical subject headings
- Critical Illness, Respiratory Insufficiency, Muscular Diseases, Asthenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sham TreatmentDevice
Also called Sham treatment without electrical stimulation
Subjects will undergo the same protocol as the treatment group except no electrical stimulation will be applied.
Electrical stimulationDevice
Two thirty minute sessions of neuromuscular electrical stimulation applied to both quadriceps for seven days for a total of 14 treatments
| Study group | Role | What they receive |
|---|---|---|
| Sham Treatment | Sham comparator | Sham stimulation twice daily Receives: Device: Sham Treatment |
| Active Treatment | Active comparator | The active treatment group will receive neuromuscular electrical stimulation to both quadriceps muscle for 30 minutes twice daily for a total of 14 treatments. Receives: Device: Electrical stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Technical Feasibility, that is ability to complete therapy sessions
Percentage of patients who completed treatment with the device
Measured: Discharge from ICU, Average 7-10 days
Secondary outcomes (5)
Total ICU length of stay
Average 7-10 days
Measured: Discharge from ICU, Average 7-10 days
Hospital Length of Stay
Average 14-21 days
Measured: Hospital discharge, Average 14-21 days
Functional Status Score for ICU
Average 7-10 days after study entry
Measured: ICU discharge, Average 7-10 days after study entry
Duration of mechanical ventilation after study entry
Average 4-10 days
Measured: Until patient is successfully weaned from mechanical ventilation, Average 4-10 days
Change in quadriceps twitch force generation
Quadriceps twitch force generation will be measured using magnetic stimulation of each femoral nerve and compared to measurements obtained at the time of study entry (baseline-prior to randomization)
Measured: Baseline (prior to Treatment) and Day 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2014 (estimated)
- Study startDec 2016
- Primary completionFeb 2018
- Study completionFeb 2018
Why it stopped: difficulty meeting enrollment goals
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Critical IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 2 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gerald Supinski
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Gerald Supinski, University of Kentucky
- Investigators
- Gerald S. Supinski, MD, Principal investigator, Professor of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02247895
- Sponsor's protocol ID
- 062014
- Other IDs
- 14-0237-F3R
- Status last verified
- Jun 2020
- First submitted
- 2 Sep 2014
- Last updated
- 22 Jun 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 22 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Treatment With the Niveus Medical Muscle Stimulation System 110 on Quadriceps Strength In Mechanically Ventilated Patients
- ClinicalTrials.gov ID
- NCT02247895
- Acronym / sponsor ID
- 062014
- Conditions
- Critical Illness, Respiratory Failure, Myopathy, Weakness
- Keywords
- ICU Acquired weakness, Critical illness, Mechanical ventilation
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: difficulty meeting enrollment goals
- Enrolment
- 2 participants (actual)
- Lead sponsor
- Gerald SupinskiUniversity, hospital or other
- Study start
- Dec 2016
- Primary completion
- Feb 2018 (actual)
- Study completion
- Feb 2018 (actual)
- First posted
- 25 Sep 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients who are admitted to the intensive care unit and require mechanical ventilation frequently develop profound respiratory and limb muscle weakness. Studies show that the development of weakness during the ICU stay results in poor outcomes. Currently there are no treatments for this muscle weakness, but it has been suggested that this weakness might improve with physical therapy. Electrical stimulation is a method to provide direct stimulation to the muscles potentially enhancing function and improving strength. The purpose of this study is to test the hypothesis that neuromuscular electrical stimulation of the quadriceps muscle will improve muscle strength in patients who are critically ill on mechanical ventilation.
Detailed description
The basic study design is to:
- Obtain informed consent from patient or the patients LAR
- Randomize subjects to treatment with either:
- Sham therapy, consisting of bilateral placement of Niveus Medical Muscle Stimulation System 110 electrodes for 30 minutes twice daily without activation of the electrical circuitry of the unit, or
- Active therapy, using the Niveus Medical Muscle Stimulation System 110 electrodes to actively produce a rhythmic quadriceps contraction for 30 minutes twice daily
- Measure magnetic stimulated quadriceps twitch (QuadTw) strength bilaterally as well as ultrasound assessment of quadriceps size
- Continue sham or active treatment daily for 7 days for a total of 14 sessions
- Repeat measurements of magnetic stimulated QuadTw strength and ultrasound assessment of quadriceps size on Day 8 or before Day 8 if the subject is to be discharged from the hospital prior to the allotted duration of sham or active treatment
- Functional measurement of the patient using the Functional Status Score for the ICU (FSS-ICU) at the end of the treatment period or upon discharge
- A member of the research team will visit the subject until hospital discharge and will record total duration (days) of mechanical ventilation, duration (days) of mechanical ventilation following study entry, duration of ICU stay, ventilator weaning time (days measured from time of first spontaneous breathing trial to extubation), and total duration (days) of hospitalization
- The investigators will also review each subject's medical record on entry into the study to obtain demographic information including the following: age, sex, diagnoses, medications, reason for institution of mechanical ventilation, vital signs at the time of the initial visit, bedside parameters of mechanical ventilation use (including mode of ventilation, duration of ventilation, level of oxygen, breath volume and rate, % triggered breaths), most recent arterial blood gas values, and chest radiograph readings at the time of the initial visit. The investigators will also record the subject's weight, BMI and total intake and output values since admission to the ICU. In addition, investigators will monitor each subject's progress in the ICU daily by reviewing the subject's medical record and recording the clinical parameters as well as recording daily weights and total intake and output. These parameters will also be assessed until the time that the patient is discharged from the ICU. In addition, the investigators will record and note all physical therapy and occupational therapy sessions that the subject receives as part of the standard of care in the ICU and in the hospital up until the time of discharge. In the University of Kentucky hospital, occupational therapy records the Barthel Index at each session which uses a scale of 0-100 to assess an individual's functional independence when performing activities of daily living (ADLs). Physical therapy assesses functional status using Kansas University Hospital Physical Therapy Acute Care Functional Outcomes, which also assesses functional status in the categories of bed mobility, transfer, gait and walking distance.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Sham Treatment | Sham comparator | Device: Sham TreatmentSham stimulation twice daily |
| Active Treatment | Active comparator | Device: Electrical stimulationThe active treatment group will receive neuromuscular electrical stimulation to both quadriceps muscle for 30 minutes twice daily for a total of 14 treatments. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Acute respiratory failure requiring mechanical ventilation
Key exclusion criteria (15 listed)
- Attending physician on service determines that patient too unstable to tolerate measurements
- Patient requires > 15mcg/min norepinephrine or > 15mg/kg/min of dopamine.
- Fraction of inspired oxygen > 80% or positive end expiratory pressure > 15 cm H20 requirements.
- Cardiac pacemaker or implanted defibrillator.
- Neuromuscular blocking agents delivered within 48 hours of preceding testing.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sham TreatmentAlso: Sham treatment without electrical stimulationSubjects will undergo the same protocol as the treatment group except no electrical stimulation will be applied. | Device | Sham Treatment |
| Electrical stimulationTwo thirty minute sessions of neuromuscular electrical stimulation applied to both quadriceps for seven days for a total of 14 treatments | Device | Active Treatment |
Primary outcome
Technical Feasibility, that is ability to complete therapy sessions
Time frame: Discharge from ICU, Average 7-10 days
Percentage of patients who completed treatment with the device
5 secondary outcomes
Total ICU length of stay
Time frame: Discharge from ICU, Average 7-10 days
Hospital Length of Stay
Time frame: Hospital discharge, Average 14-21 days
Functional Status Score for ICU
Time frame: ICU discharge, Average 7-10 days after study entry
Duration of mechanical ventilation after study entry
Time frame: Until patient is successfully weaned from mechanical ventilation, Average 4-10 days
Change in quadriceps twitch force generation
Time frame: Baseline (prior to Treatment) and Day 8
Results and safety
The study was stopped early (reason given: difficulty meeting enrollment goals). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jun 2020.
Related trials for Critical Illness
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Active, not recruiting
Weighted Blankets for Agitation in Adults in the Intensive Care Unit
Psychomotor Agitation, Critical Illness
Not yet recruitingObservational study
Core Competencies in General Intensive Care Ultrasound (GenIUS): a Delphi Study
Critical Illness, Ultrasound
RecruitingObservational study
Predicting Extubation Failure Using Machine Learning
Extubation Failure, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gerald S. Supinski, MD principal investigator
Professor of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Electrical stimulation in people with Critical Illness and Respiratory Failure, run by Gerald Supinski at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 22 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: difficulty meeting enrollment goals). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Technical Feasibility, that is ability to complete therapy sessions (time frame: Discharge from ICU, Average 7-10 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2020.